Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	407,897	463,131	503,841	650,295	704,427	985,637
Market Cap Growth	-8.46%	-8.08%	-22.52%	-7.69%	-28.53%	36.03%
Enterprise Value	350,637	412,429	409,238	545,580	602,944	888,822
Last Close Price	5487.00	6110.34	6545.86	8584.51	8506.77	11761.20
PE Ratio	35.37	46.01	24.77	32.48	35.73	51.32
Forward PE	30.32	30.11	24.52	33.46	34.40	48.90
PS Ratio	2.50	2.80	2.91	3.91	4.54	6.55
PB Ratio	1.92	2.17	2.46	3.29	3.60	5.40
P/TBV Ratio	2.10	2.40	2.75	3.52	3.85	5.81
P/FCF Ratio	-	-	89.91	37.88	37.56	48.82
P/OCF Ratio	-	41.18	27.44	20.38	31.42	41.09
PEG Ratio	2.43	-	20.43	13.39	11.08	7.89
EV/Sales Ratio	2.15	2.49	2.36	3.28	3.88	5.91
EV/EBITDA Ratio	12.15	12.60	12.92	17.12	19.59	29.71
EV/EBIT Ratio	18.10	16.69	15.97	20.58	23.23	34.44
EV/FCF Ratio	-	-	73.03	31.78	32.15	44.02
Debt / Equity Ratio	0.00	0.00	0.01	0.00	0.00	0.00
Debt / EBITDA Ratio	0.02	0.03	0.03	0.02	0.02	0.02
Debt / FCF Ratio	-	-	0.18	0.05	0.03	0.03
Asset Turnover	0.64	0.62	0.66	0.65	0.63	0.64
Inventory Turnover	2.65	3.37	3.88	4.51	4.55	4.47
Quick Ratio	2.32	2.48	2.37	2.94	3.24	2.94
Current Ratio	3.12	3.11	2.82	3.34	3.59	3.28
Return on Equity (ROE)	5.54%	4.81%	10.10%	10.18%	10.43%	10.81%
Return on Assets (ROA)	4.73%	5.80%	6.12%	6.52%	6.61%	6.84%
Return on Invested Capital (ROIC)	9.55%	13.03%	17.18%	20.94%	21.02%	21.65%
Return on Capital Employed (ROCE)	8.80%	11.30%	12.10%	13.00%	12.90%	13.70%
Earnings Yield	2.83%	2.17%	4.04%	3.08%	2.80%	1.95%
FCF Yield	-	-3.20%	1.11%	2.64%	2.66%	2.05%
Dividend Yield	1.91%	1.67%	1.54%	1.05%	0.98%	0.66%
Payout Ratio	-	74.55%	35.52%	32.51%	31.71%	30.12%
Buyback Yield / Dilution	0.24%	1.98%	1.67%	1.27%	0.05%	0.32%
Total Shareholder Return	2.15%	3.65%	3.21%	2.32%	1.03%	0.98%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.